Austria vs France: HICP - Tea, mate and other plant-derived products for infusion (ND)
Austria
0.6
in 2026
France
0.57
in 2026
Austria rank
20th
France rank
21st
HICP - Tea, mate and other plant-derived products for infusion (ND) over time
- Austria
- France
How they compare
Austria currently reports 0.6 against 0.57 in France, a difference of 0.03.
That makes Austria's figure about 1.1 times France's.
The two have swapped places 4 times across 31 shared years of data; in 1996 it was Austria ahead.
Austria ranks 20th and France ranks 21st of 27 countries.
Across the 4 decades both report, Austria averaged higher in 2 and France in 2.
Head to head by decade
| Decade | Austria | France | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 1.27 | 0.555 | 0.7175 | Austria |
| 2000s | 1.03 | 0.619 | 0.407 | Austria |
| 2010s | 0.808 | 0.82 | 0.012 | France |
| 2020s | 0.7657 | 0.9414 | 0.1757 | France |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hicp - tea, mate and other plant-derived products for infusion (nd), Austria or France?
- Austria, at 0.6 against 0.57 in France as of 2026.
- What is the difference in hicp - tea, mate and other plant-derived products for infusion (nd) between Austria and France?
- 0.03, with Austria ahead.
- How many years of comparable data are there for Austria and France?
- 31 years are reported by both, from 1996 to 2026.
- How do Austria and France rank globally for hicp - tea, mate and other plant-derived products for infusion (nd)?
- Austria ranks 20th and France ranks 21st of 27 countries.
- Where does this data come from?
- European Central Bank, published as HICP - Tea, mate and other plant-derived products for infusion (ND) (Neither seasonally nor working day adjusted, Sub-index weight). Statizoid refreshes it automatically from the source and publishes the full history for both places.